Larimar Therapeutics LRMR Stock Pricing Evaluation Q4 2025 Profit Disappoints BROS Dutch Bros Inc posts sizable Q4 2025 earnings beat and robust revenue growth but shares edge lower today GLIBA GCI Liberty Inc Series A GCI Group posts Q4 2025 EPS of 124 with shares climbing slightly in todays trading session FCUV Focus Universal quarterly results lack financial metrics as company shifts focus to new product strategy and market positioning Woodside beats Q4 earnings by 34 but WDS drops 16 as revenue decline outlook concerns weigh RGNT Regentis Biomaterials reports quarterly earnings CEO emphasizes strategic priorities in orthobiologics market expansion PSQ Holdings PSQH Stock Analysis Buy or Sell Q4 2025 EPS Misses Estimates